Liver Transplantation Clinical Trials

7 recruiting

Frequently Asked Questions

Common questions about Liver Transplantation clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 4

HOPE Against Cancer Recurrence in HCC

HCCLiver TransplantationOncological Outcomes
Philipp Dutkowski220 enrolled37 locationsNCT06717919
Recruiting

Renal Biopsies in Post-liver Transplantation Patients With Renal Impairment

Liver TransplantationRenal Insufficiency, Chronic
RenJi Hospital369 enrolled2 locationsNCT05326399
Recruiting
Not Applicable

En Bloc Resection of the Liver and Pancreas With a "Non-touch" Technique Followed by Liver Transplantation to Improve the Overall Survival in Patients With Non-resectable Hilar Cholangiocarcinoma Beyond the Mayo Clinic Transplant Criteria

Cholangiocarcinoma RecurrentCholangiocarcinoma Non-resectableLiver Transplantation
Oslo University Hospital15 enrolled1 locationNCT06850753
Recruiting
Not Applicable

Hepatic and Systemic Hemodynamic Modeling During Liver Surgery

Liver DiseasesLiver Transplantation
Assistance Publique - Hôpitaux de Paris150 enrolled1 locationNCT05339984
Recruiting
Not Applicable

Fecal Microbiota Transplantation for the Prevention of Infectious Complications After Liver Transplantation

Fecal Microbiota TransplantationOrthotopic Liver TransplantationMulti-drug Resistant Bacteria
IRCCS Azienda Ospedaliero-Universitaria di Bologna144 enrolled1 locationNCT06782880
Recruiting
Phase 2

Downstaging Protocol Containing Immunotherapy for HCC Beyond the Milan Criteria Before Liver Transplantation

Hepatocellular CarcinomaLiver Transplantation
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University59 enrolled1 locationNCT05475613
Recruiting

Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma

Hepatocellular CarcinomaLiver TransplantationPrognostic Biomarker+1 more
University Hospital, Ghent500 enrolled1 locationNCT05866783
Recruiting
Phase 3

Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma Beyond Milan/UCSF Criteria Who Underwent Liver Transplantation

Hepatocellular CarcinomaLiver Transplantation
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School40 enrolled1 locationNCT04595864